Biologics | American Academy of Orthopaedic Surgeons

As the world’s largest medical association of musculoskeletal specialists, the AAOS continues our commitment to deliver accurate and evidence-based information to advance the quality of musculoskeletal health. Efforts related to orthobiologics and musculoskeletal care and treatment are intended to help guide orthopaedic surgeons and vastly improve patient care within the biologics space.

AAOS Biologics Dashboard

The AAOS Biologics Dashboard is an online tool designed to help orthopaedic surgeons navigate the approval status of biologic-based interventions. It combines the most recent and readily available clinical evidence with guidance released by the FDA and will stay current as the orthobiologics therapies evolve. For more information, please see the Dashboard FAQs.

Leading the Way in Biologics

Martha Murray, MD, FAAOS
Professor of Orthopaedic Surgery
Boston Children's Hospital and Harvard Medical School

Hear more from our experts

Technology Overviews

Technology Overviews use systematic review methodology to summarize findings of current studies on a given topic for a specified patient population.

AAOS & OREF Partner to Help Fund Targeted Clinical Research

Narrowing the gap between clinical research funding and clinical research needs in orthopaedic care. Learn more at OREF.

Biologics News

Find the latest news, hear from experts, and learn more about evidence-based medicine related to orthobiologics.

AAOS Biologics Initiative

Leading the way in biologics knowledge, evidence-based discovery, and application for surgeons and patients.

Biologics Knowledge Base

Gain insights into the world of biologics and view findings from a recent AAOS review: “Understanding the State of Biologics.”

Biologics Resources

AAOS is leading the way in evidence-based medicine as it pertains to the field of orthobiologics and the future of patient care.

Committee on Devices, Biologics, and Technology

Striving to influence all aspects of orthopaedic medicine including devices, biologics, and drugs.